COMMUNIQUÉS West-GlobeNewswire

CLS Holdings USA Closes Acquisition of Oasis Cannabis
28/06/2018
Enters the Legalized Cannabis Market in Las Vegas, NV Currently Generating Approximately $850,000 per Month in Revenue LAS VEGAS, June 28, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB:CLSH) “CLS,” a [...]
Cellectar Announces Expansion of Diffuse Large B-Cell Lymphoma Cohort in CLR 131 Phase 2 Trial
28/06/2018
Response rate in cohort exceeded pre-specified value MADISON, Wis., June 28, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), a clinical-stage biopharmaceutical company focused on the discovery, [...]
Flatiron Health CMO/CSO Joins CareDx Board of Directors
28/06/2018
Amy Abernethy adds clinical expertise and patient data insights to the CareDx Board BRISBANE, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ:CDNA), a molecular diagnostics company focused on the [...]
Zafgen Announces Pricing of Offering of Common Stock
28/06/2018
BOSTON, June 28, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc., (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary MetAP2 biology platform to develop novel therapies for patients affected by [...]
Cocrystal Pharma Commences Enrollment and Initiates Patient Dosing in Phase 2a Study Evaluating CC-31244 for the Treatment of HCV
28/06/2018
- Topline results from Phase 2a study expected to be announced before year end - ATLANTA, GA and BOTHELL, WA, June 28, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a [...]
Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand
28/06/2018
WALTHAM, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into an agreement with [...]
Kura Oncology Announces Pricing of $67 Million Public Offering of Common Stock
28/06/2018
SAN DIEGO, June 28, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced the pricing of [...]
MPI: Orphan Drug designation on Oncology Venture's dovitinib for Adenoid Cystic Carcinoma
28/06/2018
Hoersholm, Denmark, June 28, 2018 -Medical Prognosis Institute A/S (MPI:ST) and Oncology Venture AB (OV:ST) announces that the Office of Orphan Products Development at the FDA has transferred the Dovitinib Orphan drug [...]
Kymab Announces Agreement to Evaluate KY1044, its Novel Antibody Targeting ICOS, and Anti-PD-L1 Immunotherapy for testing in Multiple Solid Tumors
28/06/2018
Kymab Announces Agreement to Evaluate KY1044, its Novel Antibody Targeting ICOS, and Anti-PD-L1 Immunotherapy for testing in Multiple Solid Tumors Phase I/II studies will evaluate Kymab’s lead investigational therapy [...]
Helius Medical Technologies, Inc. Announces MRI Confirmatory Evidence of Neuroplastic Change after Investigational PoNS™ Treatment Presented at the 2018 Joint Annual Meeting ISMRM – ESMRMB in Paris, France
28/06/2018
NEWTOWN, Pa., June 28, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, announced today that an [...]
Arsanis Provides Update Following Completion of Planned Interim Analysis of Phase 2 Clinical Trial of ASN100
28/06/2018
Trial Unlikely to Meet Primary Efficacy Endpoint; Arsanis to Cease Trial Enrollment and Evaluate Complete Clinical Trial Dataset Arsanis to Continue Focus on Development of ASN500 for Prevention of RSV Infection WALTHAM [...]
Capricor Therapeutics to Present at PPMD Annual Conference
28/06/2018
Poster Presentation on Pre-clinical Research of CAP-2003 in Disease Model of Duchenne Muscular Dystrophy LOS ANGELES, June 28, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics ’ (NASDAQ:CAPR) chief medical officer, [...]
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering
28/06/2018
MALVERN, Pa., June 28, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality of life for patients who [...]
Innovate Biopharmaceuticals Enters into an R&D Collaboration on Larazotide’s Corrective Effect on the Dysfunctional Intestinal Barrier and the Dysfunctional Microbiome in various Diseases with the University of Maryland School of Medicine
28/06/2018
RALEIGH, N.C., June 28, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals Inc . (Nasdaq:INNT), a clinical stage biotechnology company focused on developing novel medicines for autoimmune and inflammatory diseases, [...]
ProQR Initiates Phase 1/2 Clinical Trial of QR-313 for Dystrophic Epidermolysis Bullosa
28/06/2018
The trial, called WINGS, will evaluate the safety and efficacy of QR-313 in subjects with recessive dystrophic epidermolysis bullosa due to mutations in exon 73 of the COL7A1 gene. QR-313 is a first-in-class potential [...]
Dynavax Appoints Scientific Advisory Board to Support its Oncology and Vaccine Programs
28/06/2018
Board Comprises Six Members with Notable Contributions to the Fields of Oncology and Immunology BERKELEY, Calif., June 28, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced the [...]
Hydropothecary reports fiscal 2018 third quarter results
28/06/2018
GATINEAU, Quebec, June 28, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (TSX:HEXO) (the "Company") reported its financial results for the three and nine months ended April 30, 2018, the third quarter of the [...]
Hydropothecary déclare les résultats du troisième trimestre de l’exercice 2018
28/06/2018
GATINEAU, Québec, 28 juin 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (TSX:HEXO) (la « Société ») a publié ses résultats financiers pour les périodes de trois et neuf mois closes le 30 avril 2018, à savoir le [...]
PotNetwork Holdings, Inc. Exhibits Swiftly Growing MediPets Line at Industry Leading SuperZoo Event
28/06/2018
MediPets Comes to Vegas Bringing the Latest in Pet CBD to the Largest Industry Event Geared Toward Professionals and Consumers Seeking Cutting-Edge Products and Education FT. LAUDERDALE, Fla., June 28, 2018 (GLOBE [...]

Pages